tyrosine has been researched along with crizotinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, FQ; Sun, HY | 1 |
| Liu, H; Lu, S; Lu, T; Pan, J; Qiao, X; Xiang, B; Yan, L; Yuan, H; Zhang, L; Zhang, Y | 1 |
| Heo, CY; Jeong, JH; Kim, HY; Lee, S; Yun, JW | 1 |
3 other study(ies) available for tyrosine and crizotinib
| Article | Year |
|---|---|
A molecular dynamics investigation on the crizotinib resistance mechanism of C1156Y mutation in ALK.
Topics: Amino Acid Substitution; Anaplastic Lymphoma Kinase; Catalytic Domain; Crizotinib; Crystallography, X-Ray; Cysteine; Drug Design; Drug Resistance, Neoplasm; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Mutation; Protein Conformation; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Tyrosine | 2012 |
Insight into the key features for ligand binding in Y1230 mutated c-Met kinase domain by molecular dynamics simulations.
Topics: Binding Sites; Crizotinib; Humans; Hydrogen Bonding; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Binding; Protein Domains; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazines; Triazoles; Tyrosine | 2018 |
Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer.
Topics: Axin Protein; Colorectal Neoplasms; Crizotinib; ErbB Receptors; Humans; Receptor Protein-Tyrosine Kinases; Receptor-Like Protein Tyrosine Phosphatases, Class 2; RNA; Signal Transduction; Thrombospondins; Tumor Suppressor Protein p53; Tyrosine | 2022 |